Evaluation of the Efficacy of a Modified Live Escherichia coli Vaccine in Commercial Laying Hens Against Field Challenges at 23 or 44 Weeks of Age

In Indonesia, colibacillosis outbreaks in commercial layer flocks characterized by acute mortality and suboptimal egg production are still common. The aim of this study with duration of 46 weeks was to evaluate the protective effects of a modified live E. coli vaccine (Poulvac® E.coli) in laying...

Full description

Saved in:
Bibliographic Details
Main Authors: Untari, Tri, Betty, Yuriko, ChoewKong, Mah, Artanto, Sidna
Format: Article PeerReviewed
Language:English
Published: World Veterinary Poultry Association 2019
Subjects:
Online Access:https://repository.ugm.ac.id/277211/1/prosiding_WVPAC%20full-pages-1-3%2C6%2C15%2C26%2C207-208%2C488.pdf
https://repository.ugm.ac.id/277211/
http://wvpac2019.com
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Gadjah Mada
Language: English
id id-ugm-repo.277211
record_format dspace
spelling id-ugm-repo.2772112022-03-02T00:58:54Z https://repository.ugm.ac.id/277211/ Evaluation of the Efficacy of a Modified Live Escherichia coli Vaccine in Commercial Laying Hens Against Field Challenges at 23 or 44 Weeks of Age Untari, Tri Betty, Yuriko ChoewKong, Mah Artanto, Sidna Veterinary Sciences In Indonesia, colibacillosis outbreaks in commercial layer flocks characterized by acute mortality and suboptimal egg production are still common. The aim of this study with duration of 46 weeks was to evaluate the protective effects of a modified live E. coli vaccine (Poulvac® E.coli) in laying hens against two common serotype of avian pathogenic E. coli (APEC), namely O78 andO2 orlocally known as S strain. A total of 180 Isa Brown chicks raised under field condition were divided into two groups (unvaccinated controls, vaccinated twice at 10 days and 12 weeks of age, respectively). All birds were challenged with either a homologous E. coli strain (O78) or a heterologous challenge strain (S / O2) through intra-tracheal route (>109 mean CFU/dose). The challenge took place at either23or44weeksofagetomimic themost common periods of APEC infection. Efficacy was determined based on a reduction of APEC-associated lesions and mortality, and higher cumulative number of eggs produced per hen housed compared to the challenged controls. Thisstudy showed thediseasemanifestations and mortality were pronounced in the unvaccinated controls. Poulvac® E. coli has been demonstrated to provide 95%and97%protection againstO78 challenge at 23 and 44 weeks of age; 87% and 89% protection against a heterologous E. coli S/O2 strain challenge at two respective periods. The vaccinated layers yielded 11 more cumulative numbers of eggs per hen housed than the unvaccinated controls.Differencesin eggshell color and individual egg weight were also observed in the study. World Veterinary Poultry Association 2019-09-16 Article PeerReviewed application/pdf en https://repository.ugm.ac.id/277211/1/prosiding_WVPAC%20full-pages-1-3%2C6%2C15%2C26%2C207-208%2C488.pdf Untari, Tri and Betty, Yuriko and ChoewKong, Mah and Artanto, Sidna (2019) Evaluation of the Efficacy of a Modified Live Escherichia coli Vaccine in Commercial Laying Hens Against Field Challenges at 23 or 44 Weeks of Age. Proceeding 21st World Veterinary Poultry Association Congress (WVPAC). pp. 207-208. http://wvpac2019.com
institution Universitas Gadjah Mada
building UGM Library
continent Asia
country Indonesia
Indonesia
content_provider UGM Library
collection Repository Civitas UGM
language English
topic Veterinary Sciences
spellingShingle Veterinary Sciences
Untari, Tri
Betty, Yuriko
ChoewKong, Mah
Artanto, Sidna
Evaluation of the Efficacy of a Modified Live Escherichia coli Vaccine in Commercial Laying Hens Against Field Challenges at 23 or 44 Weeks of Age
description In Indonesia, colibacillosis outbreaks in commercial layer flocks characterized by acute mortality and suboptimal egg production are still common. The aim of this study with duration of 46 weeks was to evaluate the protective effects of a modified live E. coli vaccine (Poulvac® E.coli) in laying hens against two common serotype of avian pathogenic E. coli (APEC), namely O78 andO2 orlocally known as S strain. A total of 180 Isa Brown chicks raised under field condition were divided into two groups (unvaccinated controls, vaccinated twice at 10 days and 12 weeks of age, respectively). All birds were challenged with either a homologous E. coli strain (O78) or a heterologous challenge strain (S / O2) through intra-tracheal route (>109 mean CFU/dose). The challenge took place at either23or44weeksofagetomimic themost common periods of APEC infection. Efficacy was determined based on a reduction of APEC-associated lesions and mortality, and higher cumulative number of eggs produced per hen housed compared to the challenged controls. Thisstudy showed thediseasemanifestations and mortality were pronounced in the unvaccinated controls. Poulvac® E. coli has been demonstrated to provide 95%and97%protection againstO78 challenge at 23 and 44 weeks of age; 87% and 89% protection against a heterologous E. coli S/O2 strain challenge at two respective periods. The vaccinated layers yielded 11 more cumulative numbers of eggs per hen housed than the unvaccinated controls.Differencesin eggshell color and individual egg weight were also observed in the study.
format Article
PeerReviewed
author Untari, Tri
Betty, Yuriko
ChoewKong, Mah
Artanto, Sidna
author_facet Untari, Tri
Betty, Yuriko
ChoewKong, Mah
Artanto, Sidna
author_sort Untari, Tri
title Evaluation of the Efficacy of a Modified Live Escherichia coli Vaccine in Commercial Laying Hens Against Field Challenges at 23 or 44 Weeks of Age
title_short Evaluation of the Efficacy of a Modified Live Escherichia coli Vaccine in Commercial Laying Hens Against Field Challenges at 23 or 44 Weeks of Age
title_full Evaluation of the Efficacy of a Modified Live Escherichia coli Vaccine in Commercial Laying Hens Against Field Challenges at 23 or 44 Weeks of Age
title_fullStr Evaluation of the Efficacy of a Modified Live Escherichia coli Vaccine in Commercial Laying Hens Against Field Challenges at 23 or 44 Weeks of Age
title_full_unstemmed Evaluation of the Efficacy of a Modified Live Escherichia coli Vaccine in Commercial Laying Hens Against Field Challenges at 23 or 44 Weeks of Age
title_sort evaluation of the efficacy of a modified live escherichia coli vaccine in commercial laying hens against field challenges at 23 or 44 weeks of age
publisher World Veterinary Poultry Association
publishDate 2019
url https://repository.ugm.ac.id/277211/1/prosiding_WVPAC%20full-pages-1-3%2C6%2C15%2C26%2C207-208%2C488.pdf
https://repository.ugm.ac.id/277211/
http://wvpac2019.com
_version_ 1727155350852861952